Renate Thalhammer
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Post-transplant ring sideroblasts are common in haploidentical peripheral blood stem cell transplantation but not linked to SF3B1 mutations.
Journal: Clinical chemistry and laboratory medicine
Published: January 16, 2026
Changes in cardiac parameters during venetoclax treatment.
Journal: Haematologica
Published: January 15, 2025
Very low doses of rituximab in autoimmune hemolytic anemia-an open-label, phase II pilot trial.
Journal: Frontiers in medicine
Published: September 18, 2024
Resolution of extravascular hemolysis with oral iptacopan monotherapy in a patient with treatment experienced paroxysmal nocturnal hemoglobinuria (PNH).
Journal: Wiener klinische Wochenschrift
Published: April 27, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Journal: Blood
Published: December 22, 2023
Evaluation of the Sysmex DI-60 digital morphology analyzer on Wright-stained samples with a focus on prevalence-dependent quality indicators.
Journal: International journal of laboratory hematology
Published: June 12, 2023
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.
Journal: American journal of hematology
Published: June 20, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls.
Journal: Annals of the rheumatic diseases
Published: April 20, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.
Journal: Annals of the rheumatic diseases
Published: March 31, 2022
Erratum to: Making decisions in times of a pandemic : A qualitative study on perspectives of managers of long-term care facilities
Journal: Zeitschrift fur Gerontologie und Geriatrie
Published: March 10, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.
Journal: Nature communications
Published: February 05, 2022
Last Updated: 09/26/2026